Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Apr 7:13:876477.
doi: 10.3389/fimmu.2022.876477. eCollection 2022.

Commentary: 'Case Report: A Rare Case of Elderly-Onset Adult Onset Still's Disease in a Patient With Systemic Lupus Erythematous'

Affiliations
Comment

Commentary: 'Case Report: A Rare Case of Elderly-Onset Adult Onset Still's Disease in a Patient With Systemic Lupus Erythematous'

Marion Delplanque et al. Front Immunol. .
No abstract available

Keywords: AOSD; VEXAS syndrome; auto-inflammatory disease; autoimmunity; myelodysplastic/myeloproliferative disorders.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

Similar articles

References

    1. Riveros Frutos A, Holgado S, Sanvisens Bergé A, Casas I, Olivé A, López-Longo FJ, et al. . Late-Onset Versus Early-Onset Systemic Lupus: Characteristics and Outcome in a National Multicentre Register (RELESSER). Rheumatol Oxf Engl (2021) 60(4):1793803. doi: 10.1093/rheumatology/keaa477 - DOI - PubMed
    1. Medlin JL, Hansen KE, Fitz SR, Bartels CM. A Systematic Review and Meta-Analysis of Cutaneous Manifestations in Late- Versus Early-Onset Systemic Lupus Erythematosus. Semin Arthritis Rheum (2016) 45(6):6917. doi: 10.1016/j.semarthrit.2016.01.004 - DOI - PMC - PubMed
    1. Bouali F, Berrah A, Si Ahmed-Bouali D, Harrieche F, Benhalima M, Hamladji RM, et al. . Immunological Abnormalities in Myelodysplastic Syndromes. Prospective Study (Series of 40 Patients). Rev Med Interne (2005) 26(10):77783. doi: 10.1016/j.revmed.2005.06.012 - DOI - PubMed
    1. Mekinian A, Grignano E, Braun T, Decaux O, Liozon E, Costedoat-Chalumeau N, et al. . Systemic Inflammatory and Autoimmune Manifestations Associated With Myelodysplastic Syndromes and Chronic Myelomonocytic Leukaemia: A French Multicentre Retrospective Study. Rheumatol Oxf Engl (2016) 55(2):291300. doi: 10.1093/rheumatology/kev294 - DOI - PubMed
    1. Dalamaga M, Karmaniolas K, Matekovits A, Migdalis I, Papadavid E. Cutaneous Manifestations in Relation to Immunologic Parameters in a Cohort of Primary Myelodysplastic Syndrome Patients. J Eur Acad Dermatol Venereol JEADV (2008) 22(5):5438. doi: 10.1111/j.1468-3083.2007.02520.x - DOI - PubMed

MeSH terms